The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Nortriptyline Versus Fluoxetine in the Treatment of Depression and in Short-Term Recovery After Stroke: A Placebo-Controlled, Double-Blind Study
Abstract
OBJECTIVE: This study compared nortriptyline and fluoxetine with placebo in the treatment of depression and in recovery from physical and cognitive impairments after stroke. METHOD: A total of 104 patients with acute stroke enrolled between 1991 and 1997 entered a double-blind randomized study comparing nortriptyline, fluoxetine, and placebo over 12 weeks of treatment. The majority of patients were recruited from a rehabilitation hospital in Des Moines, Iowa, but other enrollment sites were also used. Both depressed and nondepressed patients were enrolled to determine whether improved recovery could be mediated by mechanisms unrelated to depression. Nortriptyline in doses of 25 mg/day gradually increased to 100 mg/day or fluoxetine in doses of 10 mg/day gradually increased to 40 mg/day or identical placebo were given over 12 weeks. Response to treatment of depression for individual patients was defined as a greater-than-50% reduction in scores on the Hamilton Rating Scale for Depression and no longer fulfilling diagnostic criteria for major or minor depression. Improved recovery for a treatment group was defined as a significantly higher mean score from baseline to end of the treatment trial, compared with patients treated with placebo, on measures of impairment in activities of daily living and levels of cognitive and social functioning. RESULTS: Nortriptyline produced a significantly higher response rate than fluoxetine or placebo in treating poststroke depression, in improving anxiety symptoms, and in improving recovery of activities of daily living as measured by the Functional Independence Measure. There was no effect of nortriptyline or fluoxetine on recovery of cognitive or social functioning among depressed or nondepressed patients. Fluoxetine in increasing doses of 10-40 mg/day led to an average weight loss of 15. 1 pounds (8% of initial body weight) over 12 weeks of treatment that was not seen with nortriptyline or placebo. CONCLUSIONS: Given the doses of medication used in this study, nortriptyline was superior to fluoxetine in the treatment of poststroke depression. Demonstrating a benefit of antidepressant treatment in recovery from stroke may require the identification of specific subgroups of patients, alternative measurement scales, or the optimal time of treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Rank transformations as a bridge between parametric and nonparametric statistics
Conover, W. J., & Iman, R. L. (1981) · The American Statistician · doi:10.1080/00031305.1981.10479327 · Cited by 3,922
Normative Data and Screening Power of a Shortened Version of the Token Test
De Renzi, E., & Faglioni, P. (1978) · Cortex · doi:10.1016/s0010-9452(78)80006-9 · Cited by 1,121
Ordinal Methods for Behavioral Data Analysis
Cliff, N. (2014) · Psychology Press eBooks · doi:10.4324/9781315806730 · Cited by 560
NORTRIPTYLINE TREATMENT OF POST-STROKE DEPRESSION: A DOUBLE-BLIND STUDY
Lipsey, J., Pearlson, G., Robinson, R., Rao, K., & Price, T. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90356-8 · Cited by 539
Self-citationMood change following left hemispheric brain injury
Robinson, R. G., & Szetela, B. (1981) · Annals of Neurology · doi:10.1002/ana.410090506 · Cited by 455
Self-citationComparison of Paroxetine and Nortriptyline in Depressed Patients With Ischemic Heart Disease
Roose, S. P. (1998) · JAMA · doi:10.1001/jama.279.4.287 · Cited by 453
A two-year longitudinal study of post-stroke mood disorders: findings during the initial evaluation.
Robinson, R. G., Starr, L. B., Kubos, K. L., & Price, T. R. (1983) · Stroke · doi:10.1161/01.str.14.5.736 · Cited by 436
Self-citationAndersen, G., Vestergaard, K., & Lauritzen, L. (1994) · Stroke · doi:10.1161/01.str.25.6.1099 · Cited by 378
Crisostomo, E. A., Duncan, P. W., Propst, M., Dawson, D. V., & Davis, J. N. (1988) · Annals of Neurology · doi:10.1002/ana.410230117 · Cited by 340
Cited by
Post-Stroke Depression: A Review
Robinson, R. G., & Jorge, R. E. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15030363 · Cited by 1,125
Self-citationMood disorders in the medically ill: scientific review and recommendations
Evans, D. L., Charney, D. S., Lewis, L., Golden, R. N., Gorman, J. M., Krishnan, K. R. R., Nemeroff, C. B., Bremner, J. D., Carney, R. M., Coyne, J. C., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.001 · Cited by 1,071
Self-citationManagement of Adult Stroke Rehabilitation Care: A Clinical Practice Guideline
Duncan, P. W., Zorowitz, R., Bates, B., Choi, J. Y., Glasberg, J. J., Graham, G. D., Katz, R. C., Lamberty, K., & Reker, D. (2005) · Stroke · doi:10.1161/01.str.0000180861.54180.ff · Cited by 1,046
Miller, E. L., Murray, L., Richards, L., Zorowitz, R. D., Bakas, T., Clark, P., & Billinger, S. A. (2010) · Stroke · doi:10.1161/str.0b013e3181e7512b · Cited by 758
Bauer, M., Pfennig, A., Severus, E., Whybrow, P. C., Angst, J., Möller, H.-J., & Šon behalf of the Task Force on Unipolar Depressive Disorders (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.804195 · Cited by 632
“In placebo-controlled studies, nortriptyline has been superior to placebo (Lipsey and Robinson 1984; Robinson et al. 2000), and to fl uoxetine in the treatment of post-stroke depression (Robinson et al. 2000).”
BackgroundLenze, E. J., Rogers, J. C., Martire, L. M., Mulsant, B. H., Rollman, B. L., Dew, M. A., Schulz, R., & Reynolds, C. F. (2001) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200105000-00004 · Cited by 593
Post stroke depression: epidemiology, pathophysiology, and biological treatment
Whyte, E. M., & Mulsant, B. H. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01424-5 · Cited by 488
Charney, D. S., Reynolds, C. F., Lewis, L., Lebowitz, B. D., Sunderland, T., Alexopoulos, G. S., Blazer, D. G., Katz, I. R., Meyers, B. S., Arean, P. A., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.7.664 · Cited by 462
Poststroke depression: prevalence, diagnosis, treatment, and disease progression
Robinson, R. G. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00423-2 · Cited by 460
Self-citationGeyh, S., Cieza, A., Schouten, J., Dickson, H., Frommelt, P., Omar, Z., Kostanjsek, N., Ring, H., & Stucki, G. (2004) · Journal of Rehabilitation Medicine · doi:10.1080/16501960410016776 · Cited by 455
An Evidence-Based Review of Stroke Rehabilitation
Teasell, R. W., Foley, N. C., Bhogal, S. K., & Speechley, M. R. (2003) · Topics in Stroke Rehabilitation · doi:10.1310/8yna-1yhk-ymhb-xte1 · Cited by 433
Scheidtmann, K., Fries, W., Müller, F., & Koenig, E. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05966-9 · Cited by 416
A controlled trial of antidepressants in patients with Parkinson disease and depression
Menza, M., Dobkin, R. D., Marin, H., Mark, M. H., Gara, M., Buyske, S., Bienfait, K., & Dicke, A. (2009) · Neurology · doi:10.1212/01.wnl.0000336340.89821.b3 · Cited by 414
Robinson, R. G., Jorge, R. E., Moser, D. J., Acion, L., Solodkin, A., Small, S. L., Fonzetti, P., Hegel, M., & Arndt, S. (2008) · JAMA · doi:10.1001/jama.299.20.2391 · Cited by 355
Self-citationBauer, M., Whybrow, P. C., Angst, J., Versiani, M., Möller, H.-J., & WFSBP Task Force on Treatment Guide (2002) · The World Journal of Biological Psychiatry · doi:10.3109/15622970209150599 · Cited by 346
Mortality and Poststroke Depression: A Placebo-Controlled Trial of Antidepressants
Jorge, R. E., Robinson, R. G., Arndt, S., & Starkstein, S. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.10.1823 · Cited by 339
Self-citationPoststroke Depression: A Review
Robinson, R. G., & Spalletta, G. (2010) · The Canadian Journal of Psychiatry · doi:10.1177/070674371005500602 · Cited by 315
Self-citationPost stroke depression: the sequelae of cerebral stroke
Das, J., & G.K., R. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.04.005 · Cited by 301
Improved Recovery in Activities of Daily Living Associated With Remission of Poststroke Depression
Chemerinski, E., Robinson, R. G., & Kosier, J. T. (2001) · Stroke · doi:10.1161/01.str.32.1.113 · Cited by 300
Self-citationComorbidity of depression with other medical diseases in the elderly
Krishnan, K. R. R., Delong, M., Kraemer, H., Carney, R., Spiegel, D., Gordon, C., McDonald, W., Dew, M. A., Alexopoulos, G., Buckwalter, K., et al. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01472-5 · Cited by 290
Antidepressants for depressed elderly
Mottram, P. G., Wilson, K., & Strobl, J. J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003491.pub2 · Cited by 287
Holloway, R. G., Arnold, R. M., Creutzfeldt, C. J., Lewis, E. F., Lutz, B. J., McCann, R. M., Rabinstein, A. A., Saposnik, G., Sheth, K. N., Zahuranec, D. B., et al. (2014) · Stroke · doi:10.1161/str.0000000000000015 · Cited by 286
Interventions for preventing depression after stroke
Hackett, M. L., Anderson, C. S., House, A., & Halteh, C. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003689.pub3 · Cited by 264
Ramasubbu, R., Taylor, V. H., Samaan, Z., Sockalingham, S., Li, M., Patten, S., Rodin, G., Schaffer, A., Beaulieu, S., & McIntyre, R. S. (2012) · Annals of Clinical Psychiatry · doi:10.1177/104012371202400110 · Cited by 206
Treatment of Cognitive Impairment After Poststroke Depression: A Double-Blind Treatment Trial
Kimura, M., Robinson, R. G., & Kosier, J. T. (2000) · Stroke · doi:10.1161/01.str.31.7.1482 · Cited by 197
Self-citationPsychosocial risk factors in poststroke depression: a systematic review
Ouimet, M., Primeau, F., & Cole, M. (2001) · The Canadian Journal of Psychiatry · doi:10.1177/070674370104600905 · Cited by 115
Taragano, F. E., Allegri, R., Vicario, A., Bagnatti, P., & Lyketsos, C. G. (2001) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.340 · Cited by 103
“It is of note that a recent study suggested that nortriptyline has greater ef®cacy than sertraline in the treatment of post-stroke depression (Robinson et al., 2000).”
ResultNarushima, K., Chan, K.-L., Kosier, J. T., & Robinson, R. G. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.6.1157 · Cited by 90
Self-citationPrice, A., Rayner, L., Okon-Rocha, E., Evans, A., Valsraj, K., Higginson, I. J., & Hotopf, M. (2011) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.230862 · Cited by 90
“Cognitive measures Three studies had extractable data fromcognitivemeasures.(28) 29 38 One study(38) showed a statistically significant improvement for the treatment group, one study(28) showed no statistically significant improvement for the treatment group and the third(29) showed no statistically significant improv…”
BackgroundInfluentialEffects of depression and anxiety on quality of life in five common neurological disorders
Prisnie, J. C., Sajobi, T. T., Wang, M., Patten, S. B., Fiest, K. M., Bulloch, A. G. M., Pringsheim, T., Wiebe, S., & Jette, N. (2018) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2018.03.009 · Cited by 82
A Review of Modern Antidepressants Effects on Neurocognitive Function
Biringer, E., Rongve, A., & Lund, A. (2009) · Current Psychiatry Reviews · doi:10.2174/157340009788971137 · Cited by 73
“A number of studies have compared cognitive sideeffects of SSRIs to TCAs [54, 58, 63, 64, 66, 81-83].”
BackgroundThe pharmacological management of depression
Kupfer, D. J. (2005) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2005.7.3/dkupfer · Cited by 69
Allida, S., Cox, K. L., Hsieh, C.-F., House, A., & Hackett, M. L. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003689.pub4 · Cited by 54
Emerging strategies in the treatment of poststroke depression and psychiatric distress in patients
Capaldi II, V. F., & Wynn (2010) · Psychology Research and Behavior Management · doi:10.2147/prbm.s10035 · Cited by 25
SATO, S., YAMAKAWA, Y., TERASHIMA, Y., OHTA, H., & ASADA, T. (2006) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2006.01562.x · Cited by 18
Metadata
- Authors
- Robinson, R. G., Schultz, S. K., Castillo, C., Kopel, T., Kosier, J. T., Newman, R. M., Curdue, K., Petracca, G., & Starkstein, S. E.
- Venue
- American Journal of Psychiatry
- Published
- 2000-03-01
- Volume
- 157
- Issue
- 3
- Pages
- 351-359
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2096163024
- Cited by
- 384
- References
- 25
- FWCI
- 32.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.